ABOUT

Emosis develops and provides physicians with first-in-class, on-demand and user-friendly extended products centered on lab assay kits, to be routinely performed on the rapidly growing new generation of low cost and operator friendly flow cytometers.

These products aim at providing a comprehensive blood tests panel for the bioclinical investigation of thrombosis-induced or thrombosis-complicated diseases.

These tests aim to inform physician medical decision with respect to bleeding or clotting events (or risk of) in a broad range of clinical settings, encompassing cardiovascular and neurovascular diseases, cancer, pregnancy, and pharmacological and non-pharmacological therapy management.

Our mission is to unfold the complexity of thrombosis to help changing the course of thrombotic disease for a better patient outcome.

A multinational and multidisciplinary 360° management team, highly experienced in the healthcare, hemostasis and hematology industries.

Management Board:

Supervisory Board:

We are open up to the world, with a series of international collaborations (Europe, Israel, Australia), a distribution network covering 38 countries (37 through an exclusive distribution partnership with 5-Diagnostics + Israël through our partner Enco) and a project to create a joint venture with an Israeli-American company.

Our head office is located in Illkirch, France. We opened a subsidiary in Tel-Aviv, Israel.